You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCV GT4

Showing 1 - 25 of 4,415
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

Completed
Has Results
  • HCV
  • +2 more
  • (no location specified)
Jul 28, 2021

Hepatitis C, Chronic Trial in Riyadh (Elbasvir, Grazoprevir 50-100Mg Oral Tablet)

Completed
  • Hepatitis C, Chronic
  • Elbasvir, Grazoprevir 50-100Mg Oral Tablet
  • Riyadh, Saudi Arabia
    King Fahad Medical City
Nov 18, 2020

Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

Not yet recruiting
  • Hepatitis C
  • Cirrhosis
  • (no location specified)
Jul 20, 2022

Chronic Hepatitis C Virus Infection Trial (Sofosbuvir + Simeprevir + Ribavirin)

Completed
  • Chronic Hepatitis C Virus Infection
  • Sofosbuvir + Simeprevir + Ribavirin
  • (no location specified)
May 9, 2020

Hepatitis C Virus Infection Trial (OBV/PTV/r) ± ribavirin (RBV))

Completed
  • Hepatitis C Virus Infection
  • OBV/PTV/r) ± ribavirin (RBV)
  • (no location specified)
May 9, 2020

Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)

Completed
Has Results
  • Hepatitis C Infection
  • (no location specified)
Jan 15, 2021

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

Recruiting
  • Chronic Hepatitis C Infection
  • PR4 + LDV/SOF + ASV 4 wk
  • +7 more
  • Beijing, Beijing, China
  • +1 more
Aug 27, 2021

Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets)

Completed
Has Results
  • Chronic Hepatitis C
  • Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets
  • (no location specified)
Jan 15, 2021

Biological Availability, Skin Absorption, CBD Trial in London (CBD and THC with GT4 technology)

Completed
  • Biological Availability
  • +3 more
  • CBD and THC with GT4 technology
  • London, Ontario, Canada
    KGK Science Inc.
May 30, 2022

Hepatitis C Virus Infection, Response to Therapy of Trial in Canada, United States (Test and treat plus peer mentors, Usual

Recruiting
  • Hepatitis C Virus Infection, Response to Therapy of
  • Test and treat plus peer mentors
  • Usual care
  • Birmingham, Alabama
  • +3 more
Dec 9, 2022

Chronic Hepatitis C Virus Infection Trial ((SOF and DCV), (SOF, DCV, and RBV))

Completed
  • Chronic Hepatitis C Virus Infection
  • (SOF and DCV)
  • (SOF, DCV, and RBV)
  • (no location specified)
May 13, 2020

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C
  • Hepatitis C Virus
  • (no location specified)
Jul 9, 2021

SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients

Recruiting
  • Hepatitis C
  • Epclusa (sofosbuvir and velpatasvir)
  • Guangzhou, Guangdong, China
    Deparment of Infectious Diseases, the Second Affiliated Hospital
Jul 1, 2021

Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A), Placebo to Grazoprevir 100 mg/Elbasvir 50 mg

Completed
Has Results
  • Chronic Hepatitis C
  • Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A)
  • Placebo to Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet
  • (no location specified)
Nov 11, 2019

Zepatier in Patients With Substance Use

Active, not recruiting
  • Hepatitis C
  • +3 more
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 28, 2022

Chronic HCV Infection Trial in Clermont-Ferrand (Elbasvir/Grazoprevir Fixed Dose Combination)

Completed
Has Results
  • Chronic HCV Infection
  • Elbasvir/Grazoprevir Fixed Dose Combination
  • Clermont-Ferrand, France
    CHU Clermont-Ferrand
Sep 9, 2020

Hepatitis C Trial (Grazoprevir, Uprifosbuvir, Elbasvir)

Completed
Has Results
  • Hepatitis C
  • (no location specified)
Jul 18, 2019

Chronic Hepatitis C Infection Trial in Worldwide (Ombitasvir/paritaprevir/ritonavir, Dasabuvir, Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • San Francisco, California
  • +20 more
Sep 7, 2021

Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))

Recruiting
  • Hepatitis C
  • Sofosbuvir 400mg [Sovaldi]
  • Glecaprevir/pibrentasvir (300mg/120mg)
  • Darlinghurst, New South Wales, Australia
  • +2 more
Mar 28, 2022

Chronic Hepatitis C Virus Infection Trial in Bani Sweif (SOF/SMV/DCV/RBV)

Completed
  • Chronic Hepatitis C Virus Infection
  • Bani Sweif, Egypt
    Health Administration at Beni-Seuf
May 10, 2020

HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)

Recruiting
  • HCV
  • Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
  • Cairo, Egypt
    Faculty of Medicine, Ain-Shams University Research Institute-Cli
May 2, 2023

Hepatitis C, Intravenous Drug Users Trial in Montréal (Xpert HCV Viral load, Transient elastography)

Completed
  • Hepatitis C
  • Intravenous Drug Users
  • Xpert HCV Viral load
  • Transient elastography
  • Montréal, Quebec, Canada
    Centre hospitalier de l'Université de Montréal
Jul 26, 2021

Untreated Adult Acute Myeloid Leukemia Trial in Houston (Cladribine, Guadecitabine, Idarubicin)

Completed
Has Results
  • Untreated Adult Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Apr 28, 2022

Hepatitis C Virus Infection Trial (SOF/RBV/PegINFa-2)

Completed
  • Hepatitis C Virus Infection
  • (no location specified)
May 6, 2020